The position is unambiguous: if you are subject to WADA rules, BPC-157 is prohibited, no exemption is available, detection capability is improving, and a positive test carries a minimum two-year ban under the current WADA Code, with potential lifetime bans for aggravated violations or repeat offences
The therapeutic potential of BPC-157 in healing and inflammation: A review of preclinical studies
While subcontracting portions of the work is permitted, the majority must remain within the small business
The physician evaluates the extent of infection, rules out abscess, and determines outpatient IM antibiotic therapy is appropriate
Important considerations for stacking: - Stacking requires medical supervision (don't combine peptides without provider guidance - Dosing may be adjusted when using both peptides together - Cost is higher since you're using two peptides - Track both peptides in the to maintain accurate records for your provider Making the Decision with Your Provider Choosing between TB-500, BPC-157, or both is a clinical decision